Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Dukoral Market Size And Revenue Forecast Through 2030
The increase observed during the historic period was driven by cholera epidemics in areas where the disease persists, a surge in cross-border travel, recommendations from authorities for vaccination, a longstanding presence of illnesses transmitted through water, and the growth of clinics specializing in travel medicine.
The anticipated expansion during the forecast period is largely fueled by a rise in worldwide travel movements, the wider geographic reach of cholera due to shifting climate patterns, increased investment in preventative medical services, improved oral vaccine technologies, and an intensified emphasis on safeguarding traveler well-being. Key developments shaping this period encompass a broader uptake of oral vaccination options, a surge in travel-related health inoculations, a heightened priority on combating enteric illnesses, a growing shift toward needle-free immunization methods, and deeper recognition of the threats posed by cholera and ETEC.
Download A Free Sample Report For Comprehensive Market Insights:
Dukoral Market Growth Momentum: Which Factors Are Influencing Demand?
The expected growth of the dukoral market is being propelled by an upsurge in cholera cases. As an acute diarrheal illness stemming from consuming food or water tainted with Vibrio cholerae, cholera triggers severe dehydration and, in severe instances, can be fatal. This increase in cholera is driven by factors such as inadequate sanitation, tainted water supplies, and climate change, which collectively foster favorable conditions for outbreaks. Dukoral functions as an oral cholera vaccine, working to cut down cholera cases by building immunity against the Vibrio cholerae bacteria and its toxin, thereby lowering the risk of infection. To illustrate, as per the World Health Organization (WHO), a Switzerland-based intergovernmental body, in September 2024, it was reported that cholera cases saw a 13% rise in 2023, accompanied by a notable 71% increase in deaths compared to 2022, leading to over 4,000 fatalities from a disease that is both preventable and easily treatable. Consequently, the upward trend in cholera occurrences is anticipated to drive the expansion of the dukoral market.
Dukoral Market Categorization By Product Type And Application
The dukoral market covered in this report is segmented –
1) By Indication: Cholera, Traveler’s Diarrhea
2) By Distribution Channel: Pharmacies, Travel Clinics, Healthcare Providers
3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care
Dukoral Market Trends Reshaping Industry Growth
Major industry players within the dukoral market are placing a strong emphasis on creating innovative vaccine formulations, particularly affordable oral cholera vaccines, with the goal of boosting effectiveness and streamlining how they are given. These low-cost oral vaccines offer an accessible and easily administered alternative for cholera prevention, especially in areas with limited resources. Such vaccines are taken by mouth and represent a cost-effective solution tailored to low-resource settings and regions prone to outbreaks. A concrete example occurred in April 2023, when the International Vaccine Institute (IVI), a non-profit autonomous organization headquartered in South Korea, entered into a collaboration with the University of Gothenburg, an institution based in Sweden, to develop DuoChol—an oral cholera vaccine (OCV) that is both low-cost and practical. The aim of this partnership is to push forward the development of DuoChol, which utilizes a dry formulation containing inactivated bacterial whole cells alongside the cholera toxin B subunit, all enclosed in a capsule. Its composition closely resembles that of DUKORAL, yet it boasts superior thermostability, maintains its effectiveness at elevated temperatures, and comes with a lighter and more compact form. The initial Phase I clinical trial for DuoChol is scheduled to take place in Sweden, with funding provided by the Wellcome Trust and the Swedish government.
Dukoral Market Company Landscape And Strategic Competition
Major companies operating in the dukoral market are Valneva SE
Access The Complete Dukoral Market Report:
Dukoral Market Regional Analysis: Which Region Leads By Revenue?
Asia-Pacific was the largest region in the dukoral market in 2025. The regions covered in the dukoral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model